NCT07680439 clinical trial report covering BCB-276, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07680803 clinical trial report covering GSK-2696277, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07680946 clinical trial report covering Ublituximab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07681050 clinical trial report covering Potassium Bromide, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07681271 clinical trial report covering Remibrutinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07682454 clinical trial report covering Trinitrate, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07681674 clinical trial report covering BT-7480, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07682129 clinical trial report covering ENTR-601-45, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07680764 clinical trial report covering Pumitamig, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07681089 clinical trial report covering Foscenvivint, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07681869 clinical trial report covering Nimodipine, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07680322 clinical trial report covering AV-078, Phase 2, endpoints, sponsor, geography, readout timing and development white space.